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Summary  
Routine prophylactic neonatal red cell reduction, presently achieved through premature cord 
clamping, is widely practiced worldwide. It is, and  advocated by some to avoid hyperbilirubinaemia 
and jaundice.  It also provides larger volumes for commercial cord blood stem cell collection. Routine 
first day umbilical vein venesection is a controlled and visible method of achieving the same effect 
and may be safer.  The rationale and protocol for a randomised comparison to determine which is 
better is described (the PERVERT Study) and the ethics satirised.  
 
Introduction 
Our first breath and its relationship to cord clamping literally affects us all. Presently, routine 
prophylactic neonatal red cell reduction is commonly achieved through premature cord clamping at 
birth; defined as any time before natural cessation of umbilical cord pulsations. This has two main 
consequences: firstly, restriction of the transfer of blood from the placenta to the neonate in the 
first minutes after birth; and secondly, increased blood pressure (BP) fluctuations during the liminal 
period of transition from fetal to adult circulation. Blood volume reduction typically averages 
19mls/kg (21% of the neonate’s total blood volume) or 18 mls/kg red cell volume (37% of the 
neonate’s red cell volume).1,2  Systematic reviewers examine the apologist claim that Proponents 
and apologists of premature cord clamping claim this may be beneficial because it reduces the rate 
of hyperbilirubinaemia and need for exchange transfusion.
3
  However, it increases the rate of 
neonatal anaemia and there is evidence that the BP fluctuations can cause or exacerbate cerebral 
damage.4  It is therefore important to explore alternative means of achieving the same end. 
Premature Cord Clamping (Control) 
First introduced in the 1700s, obstetricians have encouraged premature cord clamping since the 
1960s as part of ‘active management’ of the third stage of labour to prevent postpartum 
haemorrhage.5, 6  Formal investigation in the last two decades has demonstrated that whilst neonatal 
jaundice was lowered, premature cord clamping also had potentially harmful infant side-effects.
3,7,8
  
Consequently, in 2006, the cord clamping component of ‘active management’ was discarded by the 
World Health Organisation9  and the International Federation of Obstetrics and Gynaecology10.   In 
the UK, NICE initially determined there was insufficient evidence to recommend a change from 
‘normal practice’.
11 
 The Royal College of Obstetricians and Gynaecologists was also cautious about 
embracing change in the face of accumulating evidence of harm,12,13  but NICE recently updated its 
guidance to avoid clamping in the first minute.14 Although premature cord clamping has been 
abandoned in many countries, it remains entrenched, undocumented and unmonitored in the UK, 
which had one of the highest rates in Europe.
15
 This may be because circular logic advice that  the 
cord ‘should not be clamped earlier than necessary’ is unclear and unhelpful.13 Higher rates are 
noted by direct observation.16  More recent work on implementation of ‘delayed’, ‘physiological’ or 
‘wait a minute before’ clamping, in countries as far away as Peru,
17
 Norway,
18
 India
19
  and the USA
20
 
has shown the possibilities and difficulties in changing birth practices.  We cannot find work auditing 
recent UK practice.  It is unclear whether resistance to change stems from ingrained culture, clinical 
uncertainty, the wish to rapidly transfer practical (and legal) responsibility for the newborn to the 
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neonatologist,
21
 or because it has never been demonstrated that the same ends can be achieved in 
another way.   
In term infants, the blood volume reduction achieved through premature cord clamping amounts to 
around 60-75mls (a fifth of the total on average, although it can be substantially more)
1,2
 which 
shifts the ‘normal’ curve of neonatal haemoglobin concentration to the left by about 2.2 g/dl (95% CI 
-0.28 to -4.06).3 This results in clinical effects at both ends of the distribution (Figure 1). The benefit 
of premature cord clamping is a reduction in hyperbilirubinaemia and phototherapy, set against 
increased rates of anaemia and iron deficiency in the term infant, and higher blood transfusion 
requirements in the preterm.  Increased rates of hypotension are also seen in the preterm infant 
who undergoes premature cord clamping.8  These changes are thought to result from the 
combination of volume depletion and abrupt haemodynamic changes.
22
 In fetal life, the majority of 
blood flows from the heart, down the aorta and directly into the umbilical arteries and placenta, 
before returning oxygenated to the right side of the heart through the umbilical vein. Immediate 
cord clamping not only blocks the umbilical arteries, leading to an abrupt increase in cardiac 
afterload, but also blocks the umbilical vein leading to an immediate decrease in cardiac pre-load. 
The implications of this are not clear, but cerebral vascular damage may be responsible. Indeed, 
randomised trials have found that deferred cord clamping in term babies improves fine motor skills 
and social functioning at 4 years of age
23
 (Andersson O, Lindquist B, Lindgren M, Stjernqvist K, 
Domellöf M, Hellström-Westas L. Effect of Delayed Cord Clamping on Neurodevelopment at 4 Years 
of Age: A Randomized Clinical Trial. JAMA Pediatr. 2015 Jul;169(7):631-8), whilst randomised trials of 
premature babies show a reduction in These disturbances may be the source of the increased 
periventricular haemorrhages
8
 and neonatal mortalityexcess deaths seen in clinical trials.
23,24,25,26
   
Routine prophylactic red cell depletion through premature cord clamping is entrenched in the 
birthing culture of many maternity units despite the lack of evidence base and newer 
recommendations.
14 
 Fortuitously,  it enhances the volume of cord blood for stem cell collection, 
thus providing a strong commercial and potential future int rest.  This has led some to persist with 
premature cord clamping, and the reduction in neonatal hyperbilirubinaemia is commonly given as a 
reason for this. A reduction in inpatient neonatal surveillance is also claimed to be increase the 
importance of this, as some parents, and NHS managers, aim for postnatal discharge even before 
collection of the 10 minute APGAR score.  However, rRather than berate the evidence laggards or 
blame ‘vampire capitalism’, we have applied ‘realist’ and ‘harm reduction’ theory to explore a safer 
and more controlled way to achieve the same end; a tailored neonatal blood volume reduction 
without associated haemodynamic fluctuations.  
Routine day 1 umbilical vein venesection (Innovation) 
This pioneering , gentle method of venesection aims to  achieve precise red cell volume reduction 
slowly, visibly and safely without significant adverse effects. As traditional cord clamps require 
special cutters to be removed, we propose using a sterilized freezer bag clip at birth that can be 
released a few hours later.  An umbilical vein catheter will be inserted, followed by blood drainage 
over half an hour.  This will also make routine collection of neonatal stem cells simpler as the blood 
can be stored directly in a sterile blood bag with anticoagulant (Figure 2).  Despite the theoretical 
advantages of this controlled neonatal volume depletion, it is unclear whether replacing premature 
cord clamping with a policy ofthe benefits of routine umbilical vein venesection will reduce the rate 
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of cerebral damage and thus improve cognitive function. We will also seek to determine whether the 
policy change isare clinically and cost-effective, and, crucially, whether the procedure would be 
acceptable to parents. A randomised trial will compare the two interventions. 
Proposed Trial Protocol 
Participants: All pregnant women at 2 large university teaching hospitals  will be invited to 
participate at booking.  
Exclusion criteria: Mothers who are not prepared to be randomised before birth, or who insist on 
“natural/physiological” third stage or deferred cord clamping.  Neonates with cardiac complications 
(who may be put at risk by the marked blood pressure fluctuations or hypovolaemia associated with 
premature cord clampingvolume depletion, possibly more so during transition immediately 
following birth). No exclusions for place of birth, gestation, multiple pregnancy or condition at birth.  
Study Procedures 
1. Premature cord clamping (control): Routine cord clamping within 30 seconds of birth. No 
umbilical venesection permitted except for indicated tests.  All volumes of blood (including from 
peripheral vessels and ’heel prick’ tests) to be recorded).  
2. Controlled uUmbilical vein venesection (intervention): The cord will only be clamped once it has 
stopped pulsating or at least 5 minutes after birth, irrespective of mode of delivery. Those babies 
appearing to need immediate care will be assessed, stabilised and resuscitated at the bedside with 
the cord intact using the LifeStart Trolley, a portable BASICS bedside resuscitation trolley
276
 (see 
competing interest statement). All neonates will subsequently have their umbilical cord clamp 
released between 4 and 24 hours postpartum, an umbilical vein catheter inserted and 19mls/kg of 
blood will be gradually drained over 60 minutes with cardiovascular monitoring. The blood will be 
discarded hygienically unless required for clinical tests or retained as part of a stem cell collection 
programme.  Venesection might be associated with some maternal emotional distress, and this will 
be minimised by completing the intervention “out of sight” in an examination room on the postnatal 
ward or on the neonatal unit.  
Outcomes: Primary outcome:  Mild developmental delay and/or behaviour problem at 18 months as 
determined by the Bayley III Cognitive Scale. Secondary outcomes: Rates of postnatal hypotension, 
periventricular haemorrhage, cerebral infarcts, hyperbilirubinaemia, phototherapy, exchange 
transfusion, anaemia and need for special care admission or transfusion in the first week of life, iron 
storage at 3 and 6 months. Alongside death, other adverse effects will be collected:  need for 
resuscitation or oxygen, hypotension, periventricular haemorrhage, hypothermia and respiratory 
distress syndrome relating to premature cord clamping; and bleeding, hypotension, umbilical vein 
occlusion, vessel puncture or sepsis relating to umbilical vein venesection. Volume of blood retrieved 
for commercial stem cell collection. At 1, 3 and 12 months, parents will be asked to fill in 
questionnaires about baby behaviour and feeding as well as standard modified Edinburgh post-natal 
depression and post-traumatic stress scores. Rates of parental distress, hyperventilation and 
collapse during the venesection procedure will also be monitored as a secondary safety outcome. 
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Reporting: Once funded, the trial will be registered in a WHO-approved public trial registry. 
EQUATOR reporting guidelines287 will be followed for publication. Dissemination will include 
becoming a WHO approved standard of care for safety. 29 
Randomisation: Wwomen will be recruited antenatally and randomised online after participant 
registration. Randomisation lists, stratified by gestation will be generated electronically at the 
clinical trials unit. 
Statistics:  The number of babies with primary outcome will be compared between groups using chi-
square tests. Multivariable logistic regression models will be used to adjust for stratification factors 
used at randomisation and any other baseline clinical covariates (e.g. gestational age, mode of 
delivery, weight and condition at birth.). Covariates to be used will be pre-specified prior to analysis 
in a detailed statistical analysis plan. 
Power calculation: To demonstrate a 10% reduction in the relative risk of mild developmental delay 
and/or mild behaviour problems from 30% to 27% at 18 months would require 7,242 children (alpha 
0.05, power 80%).  With a conservative anticipated 12% recruitment rate from the two units 
(combined 16,000 deliveries per annum),  rRecruitment is expected to take 4 years. 
Ethics: Parents currently receive reassurance from a variety of sources that premature cord clamping 
and cord blood collection is entirely safe (e.g. maternity professionals, government agencies, stem 
cell collection companies). Presently, no formal consent is required or obtained for premature cord 
clamping, its timing is rarely recorded. Nevertheless, a detailed information sheet will be prepared 
explaining that the practices of premature cord clamping and umbilical vein venesection both carry 
similar theoretical risks, although these are likely to be less with slower, controlled venesection 
based on confirmed birth weight.  We see no ethical objections to this trial, and research ethics 
approval is awaited.  
Qualitative analysis: Face-to-face interviews will be conducted by study specific research nurses, 
audio-taped (with permission) and field notes taken. These will focus on mothers’ views of the two 
procedures, and the perceived effect on the child, bonding and feeding, as well as the involvement 
and view of the partner.  Any parental concerns about safety compared to ‘normal’ or ‘natural’ will 
be considered ‘cultish’ and not explored further. 28 
Economic analysis: The economic case will be examined by comparing the cost of setting up and 
running a service with the outcomes and profits it achieves. Estimates will be made for lifelong costs 
of different infant outcomes. Costs of pain and suffering, plus costs to various public sector agencies 
are derived using Hospital Inpatient Episode data and notional reference data. The medium to long-
term consequences of red cell reduction are unknown (due to lack of routine data collection of 
clamping time and minimal research).  The process necessarily rests on assumptions whose accuracy 
cannot be audited. The resulting uncertainty will be recognised in a Monte Carlo simulation. Because 
analysis is dependent upon plausible assumptions not founded on data, a policy of optimistic 
guesstimates will be adopted throughout. Costs of equipment, professional time, monitoring and 
cots will be offset by the commercial exploitation of resultant blood products. Given the epigenetic 
implications, we will apply for a 50 year follow up study.   
Future Policy and Research 
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Having described the rationale and details of the routine prophylactic PrEmature cord clamping vs 
Routine umbilical vein VEnesection blood volume ReducTion study (or ‘PERVERT’), we invite 
researchers worldwide to join this exciting collaboration. In the event that the trial shows umbilical 
vein venesection is superior to premature cord clamping but causes more maternal anxiety, then 
future research might concentrate on modifications; e.g. night-time venesection whilst parents are 
asleep might be used to allay worries, or listening to reassuring music or watching videos. It is 
postulated that routine venesection would become less traumatic to parents with time and 
familiarity, and could even be incorporated into popular culture.  New rituals might be developed 
whereby the father is encouraged to participate in the 'releasing of tension' through the draining of 
blood. These might build on recent fashions in high income countries for paternal cord cutting as a 
rite of passage to separate the mother from her baby.  Alternatively, Hospital Chaplaincy Services 
might conduct a short ceremony on the newborn relevant to religion and denomination (e.g. 
removing the baby’s blood as ‘penitence for original sin’ for Christians). The Blood Transfusion 
Service might use ‘baby’s first blood donation’ to encourage the blood donation amongst adults. 
Conclusion  
Within minutes of birth, around 20% of a newborn’s final blood volume is transferred from the 
placenta into the neonate. We are advocates of leaving the cord alone to allow the neonate to 
receive its total allocation of blood. However, many birth attendants still practice immediate cord 
clamping, with some arguing it reduces the amount of red cells in the neonate and prevents 
hyperbilirubinaemia. For those who believe routine prophylactic red cell depletion is necessary, we 
have designed a more controlled method of achieving the same objective.  The PERVERT study will 
establish its safety and effects on parental anxiety. Those who question the satarised ethics of this 
RCT should also examine the ethics of inaction whilst premature cord clamping continues. 
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Figure 1. Histogram showing difference in neonatal haemoglobin with and without premature cord 
clamping. * Derived from MacDonald (2008). 
 
 
* The light blue histogram data is derived from Liverpool Women’s Hospital statistics of all term babies 
admitted to neonatal intensive care unit 2005-10 at a time when routine premature cord clamping was 
practiced.  The graph shows the spread of values of term babies in a unit where routine prophylactic neonatal 
volume depletion is practiced via premature cord clamping (black line) vs physiological cord management 
(dark blue line shows the expected Haemoglobin levels derived from Cochrane meta-analysis showing a mean 
difference of 2.2 g/dl Hb in term babies; MacDonald 2008). 
Page 10 of 11
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Journal of the Royal Society of Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Under Review
Figure 2. Newborn baby receiving visible venesection on first day of life (Intervention group) aiming 
to remove a controlled and calculated fifth of the total blood volume based on birth weight 
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